Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular or cerebrovascular disease in Europe

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

  Safety study (incl. comparative)

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  ATOGEPANT
• Anatomical Therapeutic Chemical (ATC) code:
  (N02CD07) atogepant

  atogepant

Population studied

• Short description of the study population:
  Patients with migraine and significant cardiovascular or cerebrovascular disease in Europe